In B-cell lymphomas and leukemias such as marginal zone lymphoma and chronic lymphocytic leukemia (CLL), chronic antigenic activation of the B-cell antigen receptor (BCR) sustains aberrant lymphocyte behavior and uncontrolled monoclonal proliferation [1]. The gene discussed is BCR; the disease is B-cell non-Hodgkin lymphoma.